FOLLICULAR LYMPHOMA GRADE 3
Clinical trials for FOLLICULAR LYMPHOMA GRADE 3 explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA GRADE 3 trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR T-Cell therapy aims to tackle tough lymphoma
Disease control Recruiting nowThis early-stage study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to better recognize and attack cancer cells. T…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
New antibody therapy aims to keep lymphoma at bay after transplant
Disease control Recruiting nowThis early-phase study tests a drug called mosunetuzumab given after a stem cell transplant for people with aggressive B cell lymphomas that have come back or not responded to treatment. Mosunetuzumab is an engineered antibody that helps the body's immune T cells find and kill ca…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New hope for Tough-to-Treat lymphoma: experimental pill shows promise
Disease control Recruiting nowThis study tests an experimental drug called XNW5004 in 65 adults with follicular lymphoma (a slow-growing blood cancer) that has returned or stopped responding after at least three prior treatments. Participants take the drug twice daily for 28-day cycles. Researchers will measu…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC